{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:25:48Z","timestamp":1785389148227,"version":"3.55.0"},"reference-count":149,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171512","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T18:39:32Z","timestamp":1486147172000},"page":"e0171512","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets"],"prefix":"10.1371","volume":"12","author":[{"given":"Eumorphia G.","family":"Konstantakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanassios D.","family":"Velentzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios K.","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi I.","family":"Litou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania A.","family":"Konstandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini F.","family":"Giannopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ema","family":"Anastasiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerassimos E.","family":"Voutsinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Th.","family":"Tsangaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios J.","family":"Stravopodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"issue":"7130","key":"ref1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature05661","article-title":"Melanoma biology and new targeted therapy","volume":"445","author":"V Gray-Schopfer","year":"2007","journal-title":"Nature"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1471-4914(03)00006-6","article-title":"Modeling gene-environment interactions in malignant melanoma","volume":"9","author":"G Merlino","year":"2003","journal-title":"Trends Mol Med"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/edm.09.2","article-title":"Genetics and genomics of melanoma","volume":"4","author":"P Ghosh","year":"2009","journal-title":"Expert Rev Dermatol"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrc3218","article-title":"From genes to drugs: targeted strategies for melanoma","volume":"12","author":"KT Flaherty","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0025-6196(11)61033-1","article-title":"Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis","volume":"82","author":"SN Markovic","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"7510","key":"ref6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature13298","article-title":"Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53","volume":"511","author":"A Viros","year":"2014","journal-title":"Nature"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"A Slominski","year":"2004","journal-title":"Physiol Rev"},{"issue":"6212","key":"ref8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1253735","article-title":"The melanoma revolution: from UV carcinogenesis to a new era in therapeutics","volume":"346","author":"JA Lo","year":"2014","journal-title":"Science"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ncb2535","article-title":"Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma","volume":"14","author":"O Shakhova","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"7278","key":"ref10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature08658","article-title":"A comprehensive catalogue of somatic mutations from a human cancer genome","volume":"463","author":"ED Pleasance","year":"2010","journal-title":"Nature"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.18632\/oncotarget.1892","article-title":"Pathways and therapeutic targets in melanoma","volume":"5","author":"E Shtivelman","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00403-012-1223-7","article-title":"Upcoming strategies for the treatment of metastatic melanoma","volume":"304","author":"F Spagnolo","year":"2012","journal-title":"Arch Dermatol Res"},{"issue":"6892","key":"ref13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"H Davies","year":"2002","journal-title":"Nature"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrd3847","article-title":"Vemurafenib: the first drug approved for BRAF-mutant cancer","volume":"11","author":"G Bollag","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrc3760","article-title":"Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond","volume":"14","author":"M Holderfield","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"7326","key":"ref16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09626","article-title":"Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation","volume":"468","author":"R Nazarian","year":"2010","journal-title":"Nature"},{"issue":"7408","key":"ref17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature11183","article-title":"Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion","volume":"487","author":"R Straussman","year":"2012","journal-title":"Nature"},{"issue":"7408","key":"ref18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature11249","article-title":"Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors","volume":"487","author":"TR Wilson","year":"2012","journal-title":"Nature"},{"issue":"7377","key":"ref19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature10662","article-title":"RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)","volume":"480","author":"PI Poulikakos","year":"2011","journal-title":"Nature"},{"key":"ref20","article-title":"Yield of 6,000 proteins by 1D nLC-MS\/MS without pre-fractionation","author":"AK Anagnostopoulos","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"D1","key":"ref21","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gku989","article-title":"UniProt: a hub for protein information","volume":"43","author":"TU Consortium","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"W Huang da","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"W Huang da","year":"2009","journal-title":"Nature protocols"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"ref25","doi-asserted-by":"crossref","first-page":"D199","DOI":"10.1093\/nar\/gkt1076","article-title":"Data, information, knowledge and principle: back to metabolism in KEGG","volume":"42","author":"M Kanehisa","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nprot.2013.092","article-title":"Large-scale gene function analysis with the PANTHER classification system","volume":"8","author":"H Mi","year":"2013","journal-title":"Nature protocols"},{"issue":"Database issue","key":"ref27","doi-asserted-by":"crossref","first-page":"D377","DOI":"10.1093\/nar\/gks1118","article-title":"PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees","volume":"41","author":"H Mi","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"ref28","doi-asserted-by":"crossref","first-page":"D358","DOI":"10.1093\/nar\/gkt1115","article-title":"The MIntAct project\u2014IntAct as a common curation platform for 11 molecular interaction databases","volume":"42","author":"S Orchard","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"11459","DOI":"10.1038\/srep11459","article-title":"dbEMT: an epithelial-mesenchymal transition associated gene resource","volume":"5","author":"M Zhao","year":"2015","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.4061\/2009\/239204","article-title":"Proteomics: challenges, techniques and possibilities to overcome biological sample complexity","volume":"2009","author":"K Chandramouli","year":"2009","journal-title":"Hum Genomics Proteomics"},{"issue":"R2","key":"ref32","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1093\/hmg\/ddw208","article-title":"Proteomics to study DNA-bound and chromatin-associated gene regulatory complexes","volume":"25","author":"M Wierer","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ng0504-431","article-title":"The genetic association database","volume":"36","author":"KG Becker","year":"2004","journal-title":"Nat Genet"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1242\/dev.106567","article-title":"The melanocyte lineage in development and disease","volume":"142","author":"RL Mort","year":"2015","journal-title":"Development"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00018-009-8703-8","article-title":"Cellular mechanisms regulating human melanogenesis","volume":"66","author":"HY Park","year":"2009","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"AH Shain","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/bies.20767","article-title":"The origin and evolution of the neural crest","volume":"30","author":"PC Donoghue","year":"2008","journal-title":"Bioessays"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ydbio.2012.01.013","article-title":"Neural crest induction at the neural plate border in vertebrates","volume":"366","author":"C Milet","year":"2012","journal-title":"Dev Biol"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1242\/dev.105445","article-title":"Establishing neural crest identity: a gene regulatory recipe","volume":"142","author":"M Simoes-Costa","year":"2015","journal-title":"Development"},{"issue":"7302","key":"ref40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nature09161","article-title":"Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271","volume":"466","author":"AD Boiko","year":"2010","journal-title":"Nature"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nbt.1658","article-title":"Proteomics: a pragmatic perspective","volume":"28","author":"P Mallick","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"7047","key":"ref42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"LA Garraway","year":"2005","journal-title":"Nature"},{"issue":"7","key":"ref43","article-title":"Signaling Pathways in Melanogenesis","volume":"17","author":"SA D'Mello","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"21","key":"ref44","doi-asserted-by":"crossref","first-page":"30166","DOI":"10.18632\/oncotarget.7379","article-title":"SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells","volume":"7","author":"S Ashkenazi","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"e1128516","DOI":"10.1080\/23723556.2015.1128516","article-title":"Melanoma metastases caught in the AKT","volume":"3","author":"DA Kircher","year":"2016","journal-title":"Mol Cell Oncol"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma","volume":"44","author":"AA Brozyna","year":"2013","journal-title":"Hum Pathol"},{"issue":"14","key":"ref47","doi-asserted-by":"crossref","first-page":"17844","DOI":"10.18632\/oncotarget.7528","article-title":"Melanin content in melanoma metastases affects the outcome of radiotherapy","volume":"7","author":"AA Brozyna","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ijc.23664","article-title":"Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy","volume":"123","author":"AA Brozyna","year":"2008","journal-title":"Int J Cancer"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ijc.24005","article-title":"Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells","volume":"124","author":"A Slominski","year":"2009","journal-title":"Int J Cancer"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1755-148X.2011.00898.x","article-title":"L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions","volume":"25","author":"A Slominski","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"issue":"7621","key":"ref51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature19353","article-title":"Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition","volume":"537","author":"M Sciacovelli","year":"2016","journal-title":"Nature"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.abb.2014.06.030","article-title":"The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1alpha expression and HIF-dependent attendant pathways","volume":"563","author":"A Slominski","year":"2014","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ab.2008.12.017","article-title":"High-resolution magic angle spinning nuclear magnetic resonance analysis of metabolic changes in melanoma cells after induction of melanogenesis","volume":"386","author":"W Li","year":"2009","journal-title":"Anal Biochem"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10863-007-9081-2","article-title":"HIF-1 mediates the Warburg effect in clear cell renal carcinoma","volume":"39","author":"GL Semenza","year":"2007","journal-title":"J Bioenerg Biomembr"},{"issue":"21","key":"ref55","doi-asserted-by":"crossref","first-page":"31572","DOI":"10.18632\/oncotarget.7765","article-title":"Role of multifaceted regulators in cancer glucose metabolism and their clinical significance","volume":"7","author":"L Zhao","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"ref56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"GL Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/1535-7163.MCT-06-0526","article-title":"Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis","volume":"6","author":"B Fu","year":"2007","journal-title":"Mol Cancer Ther"},{"issue":"19","key":"ref58","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/0024-3205(89)90520-1","article-title":"L-tyrosine induces synthesis of melanogenesis related proteins","volume":"45","author":"A Slominski","year":"1989","journal-title":"Life Sci"},{"issue":"Pt 3","key":"ref59","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1242\/jcs.89.3.287","article-title":"Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa","volume":"89","author":"A Slominski","year":"1988","journal-title":"J Cell Sci"},{"issue":"15","key":"ref60","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1074\/jbc.M008703200","article-title":"Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine","volume":"276","author":"R Halaban","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00403-014-1523-1","article-title":"Curcumin does not switch melanin synthesis towards pheomelanin in B16F10 cells","volume":"307","author":"A Wolnicka-Glubisz","year":"2015","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"ref62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01121951","article-title":"Rapid melanization of Bomirski amelanotic melanoma cells in cell culture","volume":"3","author":"A Slominski","year":"1983","journal-title":"Biosci Rep"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01884251","article-title":"Some properties of Bomirski Ab amelanotic melanoma cells, which underwent spontaneous melanization in primary cell culture. Growth kinetics, cell morphology, melanin content and tumorigenicity","volume":"109","author":"A Slominski","year":"1985","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2013.06.005","article-title":"Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity","volume":"154","author":"CL Chaffer","year":"2013","journal-title":"Cell"},{"issue":"7176","key":"ref65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature06489","article-title":"Identification of cells initiating human melanomas","volume":"451","author":"T Schatton","year":"2008","journal-title":"Nature"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"e36762","DOI":"10.1371\/journal.pone.0036762","article-title":"Melanoma chemotherapy leads to the selection of ABCB5-expressing cells","volume":"7","author":"M Chartrain","year":"2012","journal-title":"PLoS One"},{"issue":"7161","key":"ref67","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature06159","article-title":"Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors","volume":"449","author":"C Cobaleda","year":"2007","journal-title":"Nature"},{"issue":"5","key":"ref68","first-page":"1065","article-title":"PAX4 has the potential to function as a tumor suppressor in human melanoma","volume":"33","author":"S Hata","year":"2008","journal-title":"Int J Oncol"},{"issue":"3","key":"ref69","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"S Lamouille","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"ref70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"Emt: 2016","volume":"166","author":"MA Nieto","year":"2016","journal-title":"Cell"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2008.06.005","article-title":"Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence","volume":"14","author":"S Ansieau","year":"2008","journal-title":"Cancer Cell"},{"issue":"47","key":"ref72","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1038\/onc.2011.181","article-title":"Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal","volume":"30","author":"X Fang","year":"2011","journal-title":"Oncogene"},{"issue":"3","key":"ref73","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1373\/clinchem.2010.154328","article-title":"Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay","volume":"57","author":"A Markou","year":"2011","journal-title":"Clin Chem"},{"issue":"13","key":"ref74","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1158\/1078-0432.CCR-14-1936","article-title":"Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma","volume":"21","author":"T Kawai","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"ref75","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ccr.2012.10.012","article-title":"Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1","volume":"22","author":"OH Ocana","year":"2012","journal-title":"Cancer Cell"},{"issue":"21","key":"ref76","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1074\/jbc.M112.350470","article-title":"The iron chelators Dp44mT and DFO inhibit TGF-beta-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1)","volume":"287","author":"Z Chen","year":"2012","journal-title":"J Biol Chem"},{"issue":"9","key":"ref77","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.bbadis.2015.06.009","article-title":"NDRG1 attenuates epithelial-mesenchymal transition of nasopharyngeal cancer cells via blocking Smad2 signaling","volume":"1852","author":"ZY Hu","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"ref78","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jso.24348","article-title":"Knockdown of NDRG1 promote epithelial-mesenchymal transition of colorectal cancer via NF-kappaB signaling","volume":"114","author":"J Ma","year":"2016","journal-title":"J Surg Oncol"},{"issue":"3","key":"ref79","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.0909333107","article-title":"Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival","volume":"107","author":"C Gjerdrum","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7579","key":"ref80","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature15748","article-title":"Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance","volume":"527","author":"KR Fischer","year":"2015","journal-title":"Nature"},{"issue":"7579","key":"ref81","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"X Zheng","year":"2015","journal-title":"Nature"},{"issue":"8","key":"ref82","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/ng.2330","article-title":"Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer","volume":"44","author":"Z Zhang","year":"2012","journal-title":"Nat Genet"},{"issue":"9","key":"ref83","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nbt0913-775a","article-title":"First Axl inhibitor enters clinical trials","volume":"31","author":"C Sheridan","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"8","key":"ref84","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"SL Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref85","article-title":"Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition","author":"Q Zhang","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"ref86","first-page":"440","article-title":"IL-17 induces EMT via Stat3 in lung adenocarcinoma","volume":"6","author":"Q Huang","year":"2016","journal-title":"Am J Cancer Res"},{"issue":"5","key":"ref87","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.18632\/oncotarget.6847","article-title":"Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal","volume":"7","author":"P Parajuli","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"ref88","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1078-0432.CCR-11-1406","article-title":"Notch signaling promotes growth and invasion in uveal melanoma","volume":"18","author":"L Asnaghi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"25722","DOI":"10.1038\/srep25722","article-title":"Notch2 as a promising prognostic biomarker for oesophageal squamous cell carcinoma","volume":"6","author":"C Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"8","key":"ref90","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/cas.12978","article-title":"Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma","volume":"107","author":"X Lin","year":"2016","journal-title":"Cancer Sci"},{"issue":"7","key":"ref91","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/0008-5472.CAN-15-1722","article-title":"Notch4 Signaling Induces a Mesenchymal-Epithelial-like Transition in Melanoma Cells to Suppress Malignant Behaviors","volume":"76","author":"E Bonyadi Rad","year":"2016","journal-title":"Cancer Res"},{"issue":"6","key":"ref92","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1083\/jcb.200503113","article-title":"The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands","volume":"170","author":"E Ladi","year":"2005","journal-title":"J Cell Biol"},{"issue":"5","key":"ref93","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/ddq529","article-title":"Notch inhibition by the ligand DELTA-LIKE 3 defines the mechanism of abnormal vertebral segmentation in spondylocostal dysostosis","volume":"20","author":"G Chapman","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"6","key":"ref94","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/icb.2010.154","article-title":"A cell autonomous role for the Notch ligand Delta-like 3 in alphabeta T-cell development","volume":"89","author":"GF Hoyne","year":"2011","journal-title":"Immunol Cell Biol"},{"issue":"302","key":"ref95","doi-asserted-by":"crossref","first-page":"302ra136","DOI":"10.1126\/scitranslmed.aac9459","article-title":"A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo","volume":"7","author":"LR Saunders","year":"2015","journal-title":"Sci Transl Med"},{"issue":"16","key":"ref96","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1242\/dev.124.16.3065","article-title":"Mouse Dll3: a novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryo","volume":"124","author":"SL Dunwoodie","year":"1997","journal-title":"Development"},{"issue":"3","key":"ref97","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1167\/iovs.08-2378","article-title":"Activation of the FGF2\/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells","volume":"50","author":"G Lefevre","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"19","key":"ref98","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1158\/0008-5472.CAN-12-4718","article-title":"FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer","volume":"73","author":"R Liu","year":"2013","journal-title":"Cancer Res"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/srep02899","article-title":"Upregulated expression of FGF13\/FHF2 mediates resistance to platinum drugs in cervical cancer cells","volume":"3","author":"T Okada","year":"2013","journal-title":"Sci Rep"},{"issue":"4","key":"ref100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/2159-8290.CD-14-1029","article-title":"First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway","volume":"5","author":"M Hagel","year":"2015","journal-title":"Cancer Discov"},{"issue":"26","key":"ref101","doi-asserted-by":"crossref","first-page":"39861","DOI":"10.18632\/oncotarget.9515","article-title":"Inhibition of FGF\/FGFR autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039\/GSK3052230","volume":"7","author":"C Blackwell","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"ref102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tcb.2005.12.005","article-title":"Osteopontin: role in cell signaling and cancer progression","volume":"16","author":"H Rangaswami","year":"2006","journal-title":"Trends Cell Biol"},{"issue":"17","key":"ref103","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1073\/pnas.94.17.9308","article-title":"Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty","volume":"94","author":"D Panda","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"ref104","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/onc.2013.184","article-title":"Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via alpha9beta1 integrin","volume":"33","author":"S Kale","year":"2014","journal-title":"Oncogene"},{"issue":"4","key":"ref105","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5040039","article-title":"Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition","volume":"5","author":"AN Kothari","year":"2016","journal-title":"J Clin Med"},{"issue":"1","key":"ref106","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1158\/0008-5472.CAN-07-2126","article-title":"Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms","volume":"68","author":"G Chakraborty","year":"2008","journal-title":"Cancer Res"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biomaterials.2016.05.007","article-title":"A novel small-molecule PPI inhibitor targeting integrin alphavbeta3-osteopontin interface blocks bone resorption in vitro and prevents bone loss in mice","volume":"98","author":"D Park","year":"2016","journal-title":"Biomaterials"},{"issue":"7375","key":"ref108","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10630","article-title":"A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma","volume":"480","author":"S Yokoyama","year":"2011","journal-title":"Nature"},{"issue":"7494","key":"ref109","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","volume":"508","author":"C Sun","year":"2014","journal-title":"Nature"},{"issue":"3","key":"ref110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ccell.2015.08.001","article-title":"BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition","volume":"28","author":"Z Yao","year":"2015","journal-title":"Cancer Cell"},{"issue":"1","key":"ref111","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1210\/jc.2010-1071","article-title":"Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E","volume":"96","author":"MH Lee","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"31","key":"ref112","doi-asserted-by":"crossref","first-page":"16068","DOI":"10.1074\/jbc.M116.723767","article-title":"14-3-3sigma Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun Protein","volume":"291","author":"K Raychaudhuri","year":"2016","journal-title":"J Biol Chem"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"7530","DOI":"10.1038\/ncomms8530","article-title":"The cell cycle regulator 14-3-3sigma opposes and reverses cancer metabolic reprogramming","volume":"6","author":"L Phan","year":"2015","journal-title":"Nat Commun"},{"issue":"24","key":"ref114","doi-asserted-by":"crossref","first-page":"20177","DOI":"10.18632\/oncotarget.3896","article-title":"The 14-3-3sigma\/GSK3beta\/beta-catenin\/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer","volume":"6","author":"C Peng","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"ref115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccell.2014.11.025","article-title":"14-3-3zeta turns TGF-beta's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2","volume":"27","author":"J Xu","year":"2015","journal-title":"Cancer Cell"},{"issue":"5","key":"ref116","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728222.2012.668185","article-title":"14-3-3 zeta as novel molecular target for cancer therapy","volume":"16","author":"A Matta","year":"2012","journal-title":"Expert Opin Ther Targets"},{"issue":"9","key":"ref117","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrm3640","article-title":"Phospho-Ser\/Thr-binding domains: navigating the cell cycle and DNA damage response","volume":"14","author":"HC Reinhardt","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"24","key":"ref118","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4161\/cc.5.24.3571","article-title":"Characterization of 14-3-3sigma dimerization determinants: requirement of homodimerization for inhibition of cell proliferation","volume":"5","author":"B Verdoodt","year":"2006","journal-title":"Cell Cycle"},{"issue":"3","key":"ref119","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1074\/jbc.M109.045989","article-title":"Dimerization is essential for 14-3-3zeta stability and function in vivo","volume":"285","author":"G Messaritou","year":"2010","journal-title":"J Biol Chem"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"26580","DOI":"10.1038\/srep26580","article-title":"14-3-3gamma Prevents Centrosome Amplification and Neoplastic Progression","volume":"6","author":"A Mukhopadhyay","year":"2016","journal-title":"Sci Rep"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"10075","DOI":"10.1038\/ncomms10075","article-title":"p38- and MK2-dependent signalling promotes stress-induced centriolar satellite remodelling via 14-3-3-dependent sequestration of CEP131\/AZI1","volume":"6","author":"MA Tollenaere","year":"2015","journal-title":"Nat Commun"},{"issue":"16","key":"ref122","doi-asserted-by":"crossref","first-page":"14522","DOI":"10.18632\/oncotarget.3995","article-title":"Destabilisation of dimeric 14-3-3 proteins as a novel approach to anti-cancer therapeutics","volume":"6","author":"JM Woodcock","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"ref123","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.semcdb.2011.09.012","article-title":"14-3-3 proteins as potential therapeutic targets","volume":"22","author":"J Zhao","year":"2011","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"ref124","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1016\/j.ddtec.2012.10.001","article-title":"Small molecules modulation of 14-3-3 protein-protein interactions","volume":"10","author":"M Mori","year":"2013","journal-title":"Drug Discov Today Technol"},{"issue":"5","key":"ref125","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.cmet.2016.03.016","article-title":"Differential Glutamate Metabolism in Proliferating and Quiescent Mammary Epithelial Cells","volume":"23","author":"JL Coloff","year":"2016","journal-title":"Cell Metab"},{"issue":"1","key":"ref126","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1152\/ajprenal.00554.2010","article-title":"Role of NH3 and NH4+ transporters in renal acid-base transport","volume":"300","author":"ID Weiner","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"ref127","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.cmet.2016.05.008","article-title":"Proliferating Cells Conserve Nitrogen to Support Growth","volume":"23","author":"RJ DeBerardinis","year":"2016","journal-title":"Cell Metab"},{"issue":"27","key":"ref128","doi-asserted-by":"crossref","first-page":"11121","DOI":"10.1073\/pnas.1107969108","article-title":"Ammonia-induced autophagy is independent of ULK1\/ULK2 kinases","volume":"108","author":"H Cheong","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref129","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nbt.2285","article-title":"Therapeutic targets in cancer cell metabolism and autophagy","volume":"30","author":"H Cheong","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"2","key":"ref130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4161\/auto.26863","article-title":"Inducing autophagy: a comparative phosphoproteomic study of the cellular response to ammonia and rapamycin","volume":"10","author":"LM Harder","year":"2014","journal-title":"Autophagy"},{"issue":"1","key":"ref131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"DJ Klionsky","year":"2016","journal-title":"Autophagy"},{"issue":"5","key":"ref132","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1101\/gad.2016311","article-title":"Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis","volume":"25","author":"JY Guo","year":"2011","journal-title":"Genes Dev"},{"issue":"10","key":"ref133","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4161\/auto.26123","article-title":"Autophagy is required for mitochondrial function, lipid metabolism, growth, and fate of KRAS(G12D)-driven lung tumors","volume":"9","author":"JY Guo","year":"2013","journal-title":"Autophagy"},{"issue":"4","key":"ref134","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ymgme.2010.08.002","article-title":"Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency","volume":"101","author":"AI Martinez","year":"2010","journal-title":"Molecular genetics and metabolism"},{"issue":"4","key":"ref135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10545-016-9942-0","article-title":"Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium","volume":"39","author":"SE Waisbren","year":"2016","journal-title":"Journal of inherited metabolic disease"},{"issue":"7490","key":"ref136","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature13111","article-title":"Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma","volume":"507","author":"T Bald","year":"2014","journal-title":"Nature"},{"issue":"12","key":"ref137","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nchembio.1669","article-title":"A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation","volume":"10","author":"S Lee","year":"2014","journal-title":"Nat Chem Biol"},{"issue":"22","key":"ref138","doi-asserted-by":"crossref","first-page":"19094","DOI":"10.1074\/jbc.M100244200","article-title":"Studies of propionate toxicity in Salmonella enterica identify 2-methylcitrate as a potent inhibitor of cell growth","volume":"276","author":"AR Horswill","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"ref139","doi-asserted-by":"crossref","first-page":"e1004679","DOI":"10.1371\/journal.ppat.1004679","article-title":"Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment","volume":"11","author":"BC VanderVen","year":"2015","journal-title":"PLoS Pathog"},{"issue":"5","key":"ref140","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1365-2958.2006.05155.x","article-title":"Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence","volume":"60","author":"EJ Munoz-Elias","year":"2006","journal-title":"Mol Microbiol"},{"issue":"1","key":"ref141","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jnc.13544","article-title":"2-Methylcitric acid impairs glutamate metabolism and induces permeability transition in brain mitochondria","volume":"137","author":"AU Amaral","year":"2016","journal-title":"J Neurochem"},{"issue":"4","key":"ref142","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1073\/pnas.1415151112","article-title":"Natural variations of copper and sulfur stable isotopes in blood of hepatocellular carcinoma patients","volume":"112","author":"V Balter","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"ref143","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"C Szabo","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"ref144","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1021\/pr060363j","article-title":"Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes","volume":"5","author":"A Chi","year":"2006","journal-title":"J Proteome Res"},{"issue":"3","key":"ref145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.celrep.2013.07.018","article-title":"Global proteome analysis of the NCI-60 cell line panel","volume":"4","author":"AM Gholami","year":"2013","journal-title":"Cell Rep"},{"issue":"7502","key":"ref146","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature13302","article-title":"A draft map of the human proteome","volume":"509","author":"MS Kim","year":"2014","journal-title":"Nature"},{"issue":"7502","key":"ref147","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nature13319","article-title":"Mass-spectrometry-based draft of the human proteome","volume":"509","author":"M Wilhelm","year":"2014","journal-title":"Nature"},{"issue":"7620","key":"ref148","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature19949","article-title":"Mass-spectrometric exploration of proteome structure and function","volume":"537","author":"R Aebersold","year":"2016","journal-title":"Nature"},{"issue":"9","key":"ref149","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1021\/pr800174k","article-title":"Comparative proteomic analysis of matched primary and metastatic melanoma cell lines","volume":"7","author":"M Al-Ghoul","year":"2008","journal-title":"J Proteome Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T12:26:32Z","timestamp":1658579192000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171512"}},"subtitle":[],"editor":[{"given":"Andrzej T","family":"Slominski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":149,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171512","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]}}}